Canadian Centre on Substance Use and Addiction. (2020) Exploring expanded response options to opioid harms: case studies from four Canadian clinics. Ottawa, Ont.: Canadian Centre on Substance Use and Addiction.
Preview | Title | Contact |
---|---|---|
|
PDF (Exploring expanded response options to opioid harms: case studies)
513kB |
Case studies with four Canadian primary care providers who offer responses to opioid harms that extend beyond those outlined in the guidelines of the Canadian Research Initiative in Substance Misuse. The report suggests that access to pharmaceutical opioid options could substantially improve quality of care and quality of life among people who use opioids.
B Substances > Opioids (opiates) > Opioid product
HJ Treatment or recovery method > Substance disorder treatment method > Substance replacement method (substitution) > Opioid agonist treatment (methadone maintenance / buprenorphine)
HJ Treatment or recovery method > Treatment outcome
J Health care, prevention, harm reduction and treatment > Patient / client care management
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Treatment factors
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Patient / client attitude toward treatment (experience)
J Health care, prevention, harm reduction and treatment > Treatment and maintenance > Provider / worker / staff attitude toward treatment
J Health care, prevention, harm reduction and treatment > Health care programme, service or facility
J Health care, prevention, harm reduction and treatment > Health care programme, service or facility > Substance disorder treatment unit
VA Geographic area > Canada
Repository Staff Only: item control page